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ENHANCED CHONDROGENIC DIFFERENTIATION OF HUMAN
OSTEOARTHRITIC BONE MARROW ASPIRATES MODIFIED TO
OVEREXPRESS THE TRANSCRIPTION FACTOR SOX9 VIA RAAV-
MEDIATED GENE TRANSFER IN DYNAMIC VERSUS STATIC CULTURE
CONDITIONS
J.K. Venkatesan, A. Rey-Rico, J. Frisch, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: Administration of bone marrow aspirates modiﬁed to over-
express reparative genes is a promising approach to remodel damaged
articular cartilage. The goal of this study was to test whether gene
transfer of the chondrogenic SOX9 transcription factor in human
osteoarthritic bone marrow aspirates via the potent, clinically relevant
rAAV vector stimulates the chondrogenic differentiation processes
under mechanical loading culture conditions.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-FLAG-hsox9 versus control (reporter) rAAV-luc (Fireﬂy
luciferase) constructs. Aspirates were transduced with each vector and
placed in mixed ﬁbrinogen/thrombin for over time (21 days) main-
tenance in dynamic ﬂow rotating bioreactors versus static culture
conditions using chondrogenic medium. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with safranin O and for immuno-
detection of type-II, type-I, and type-X collagen. The DNA, proteoglycan,
and type-II collagen contents were monitored by Hoechst 22358 assay,
binding to DMMB, and ELISA, respectively. Total RNAwas extracted and
reverse transcription was carried out for cDNA ampliﬁcation via real-
time RT-PCR. Ct values were obtained for SOX9, COL2A1, COL1A1, and
COL10A1, using GAPDH as a control for normalization, and fold induc-
tions relative to luc-treated samples were measured using the 2-DDCt
method. Each condition was performed in triplicate in three experi-
ments. The t-test was employed with P  0.05 considered statistically
signiﬁcant.
Results: Effective sox9 expression was observed in rAAV-FLAG-hsox9-
versus rAAV-luc-treated aspirates both in dynamic and static con-
ditions. Successful chondrogenic differentiation in the aspirates was
observed after 21 days in both types of culture by safranin O staining
and immunodetection of type-II collagen while immunoreactivity to
type-I and -X collagen was less intense when applying rAAV sox9. The
candidate sox9 treatment signiﬁcantly increased the DNA contents in
static culture versus luc but no effects were noted upon the proteo-
glycan and type-II collagen contents. In contrast, application of sox9
increased both the DNA, proteoglycan, and type-II collagen contents in
dynamic culture versus luc, with effects that were more marked than instatic condition. All ﬁndings were corroborated at the gene expression
level via real-time RT-PCR analysis.
Conclusions: Human osteoarthritic bone marrow aspirates can be
modiﬁed via rAAV to overexpress SOX9, leading to enhanced chon-
drogenesis in dynamic culture conditions, showing the value of such an
approach for the future development of novel treatments to repair
damaged articular cartilage.
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EFFECTS OF IGF-I OVEREXPRESSION ON THE CHONDROGENIC
POTENTIAL OF HUMAN BONE MARROW ASPIRATES MODIFIED VIA
RAAV GENE TRANSFER
J. Frisch, A. Rey-Rico, J.K. Venkatesan, H. Madry, M. Cucchiarini. Inst. for
Experimental Orthopaedics, Homburg, Saar, Germany
Purpose: The use of genetically modiﬁed bone marrow aspirates may
provide convenient, one-step therapeutic approaches to regenerate
injured articular cartilage. Here, we examined the effects of over-
expressing the mitogenic and pro-anabolic IGF-I factor via the potent
and safe rAAV gene transfer vectors on the reparative activities of
human osteoarthritic bone marrow aspirates.
Methods: Bone marrow aspirates were obtained from the distal femurs
of osteoarthritic patients undergoing total knee arthroplasty. All
patients provided informed consent before inclusion in the study. rAAV
vectors were prepared according to a routine protocol using the can-
didate rAAV-hIGF-I versus control (reporter) rAAV-lacZ constructs.
Aspirates were transduced with each vector and maintained in chon-
drogenic culture condition for 21 days. Transgene expression was
monitored by immunohistochemistry on parafﬁn-embedded sections
of aspirates that were also stained with toluidine blue and for immu-
nodetection of type-II collagen. The DNA and proteoglycan contents
were monitored by Hoechst 22358 assay and binding to DMMB,
respectively. Total RNA was extracted and reverse transcription was
carried out for cDNA ampliﬁcation via real-time RT-PCR. Ct values were
obtained for SOX9, ACAN, COL2A1, COL1A1, and COL10A1, using GAPDH
as a control for normalization, and fold inductions relative to luc-trea-
ted samples were measured using the 2-DDCt method. Each condition
was performed in duplicate in three experiments. The t-test was
employed with P  0.05 considered statistically signiﬁcant.
Results: Effective IGF-I expression was noted in rAAV-hIGF-I-treated
aspirates vis-a-vis control (rAAV-lacZ) condition. Enhanced chondro-
genic differentiation was observed in the aspirates after 21 days upon
IGF-I gene transfer versus lacZ as seen by a more robust toluidine blue
staining and stronger type-II collagen immunoreactivity. The candidate
IGF-I treatment also signiﬁcantly increased the DNA and proteoglycan
contents in the aspirates. These ﬁndings were corroborated at the gene
expression level by a real-time RT-PCR analysis of SOX9, ACAN, and
COL2A1. Of further note, IGF-I gene transfer also increased the expres-
sion of hypertrophic markers (COL1A1, COL10A1).
Conclusions: rAAV vectors can successfully modify human osteo-
arthritic bone marrow aspirates to overexpress IGF-I, leading to
enhanced metabolic and chondrogenic differentiation activities relative
to control treatment. Regulating IGF-I productionwill be necessary for a
tight control of terminal differentiation and hypertrophy before
adapting the present strategy to treat damaged articular cartilage.
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MICROARRAY COMPARISON BETWEEN HUMAN POLYDACTYLY
CHONDROCYTES AND ADULT KNEE CHONDROCYTES
E. Toyoda y, M. Sato y, T. Ukai y, T. Takahashi y, S. Nakamura z,
R. Matoba z, H. Akutsu x, A. Umezawa x, J. Mochida y. y Tokai Univ., Sch. of
Med., Kanagawa, Japan; zDNA Chip Res. Inc., Kanagawa, Japan; xNatl. Ctr.
for Child Hlth.and Dev., Tokyo, Japan
Purpose: To achieve our goal of treating osteoarthritis (OA) in the knee
through the use of chondrocyte sheets, we have conducted a clinical
study in which autologous chondrocyte sheets are transplanted to the
patient’s knee cartilaginous defect. From November of 2011, eight
patients with OA in the knee received autologous transplantation of
chondrocyte sheets, and as of November of 2014, successful regener-
ation of articular cartilage has been veriﬁed in all cases without any
serious adverse events. Nevertheless, this treatment method of autol-
ogous transplantation requires two surgeries for both harvesting and
transplantation, and limitations on the quantity and quality of cell
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alleviate such issues, we have been investigating the use of allogeneic
chondrocyte sheets for knee cartilage repair. In another ongoing clinical
study, chondrocytes obtained from surgery of young polydactyly
patients are being stocked and used, as necessary for transplantation, to
create chondrocyte sheets. The polydactyly chondrocyte sheets will
then be transplanted to patients, and the safety and effectiveness of
treatment are to be evaluated as endpoints in this study.
To establish chondrocytes derived from polydactyly patients as a source
for cell sheets, we have previously veriﬁed their safety by performing
subcutaneous transplantation to severely immunodeﬁcient mice (NOG
mice) to test for tumorigenicity, array CGH, and G band for karyotype
analysis. To further evaluate the properties of polydactyly chondrocytes
in this study, we conducted a comparative microarray analysis of
chondrocytes obtained from young polydactyly patients and those
obtained from adult knees. We report genes unique to polydactyly
chondrocytes, and several miRNA candidates that may be responsible
for modulating their gene expression.
Methods: Experiments were performed under the approval and guid-
ance of the Clinical Research Review Committee of Tokai University
School of Medicine. Informed consents were obtained in all cases.
Cartilaginous tissue from young polydactyly patients (6 patients; age,
11-16 months; average age, 13 months) was collected, minced, and
digested in collagenase, and the isolated cells were cultured and treated
as polydactyly chondrocytes. Cartilaginous tissue from non-loading
parts of knees of adult patients with anterior cruciate ligament (ACL)
injury (3 patients; age, 15-31 years; average age, 22.3 years) was
obtained, and adult knee chondrocytes were similarly isolated and
cultured. Total RNAwas extracted from both cultured chondrocytes, and
Agilent Human GE 4x44K v2 and Agilent Human miRNA Microarray
(V3) 8x15k were utilized to map gene and miRNA expressions,
respectively. Agilent GeneSpring GX version 11.0.2 was used to identify
and analyze genes and miRNAs with changes in expression of greater
than 1.5 fold (student t-test P-value < 0.05).
Results: Microarray data from polydactyly chondrocytes (n¼6) and
adult knee chondrocytes (n¼3) were obtained and analysis was per-
formed on probes showing signiﬁcant signals in 2 or more samples. We
identiﬁed differences in gene expression between polydactyly chon-
drocytes and adult knee chondrocytes in 2,323 out of 23,678 probes.
Out of the 2,323 probes, 1,304 had higher expression and 1,019 probes
had lower expression in polydactyly chondrocytes. Furthermore, of the
140 probes for miRNA expression, 8 probes had higher expression and
22 had lower expression in polydactyly chondrocytes. Pathway analysis
identiﬁed no less than 3 miRNA candidates that may regulate gene
expression of key genes in polydactyly chondrocytes compared with
adult knee chondrocytes.
Conclusions: We were able to identify several miRNA candidates
characterize the difference between polydactyly chondrocytes and
adult knee chondrocytes. Through further studies, we may be able to
use synthetic nucleic acids that mimic miRNA activity to give young
polydactyly chondrocytes adult-like characteristics.
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CARTILAGE REGENERATION AND INTERMITTENT HYDROSTATIC
PRESSURE: A ROLE FOR MSCS
K. Dijkstra y, S.C. Mastbergen y, H.B. Karperien z, F.P. Lafeber y. yUniv.
Med. Ctr. Utrecht, Utrecht, Netherlands; zUniv. of Twente, Enschede,
Netherlands
Purpose: Cartilage regeneration is observed after joint distraction in the
treatment of severe knee osteoarthritis (Wiegant et al 2013). More than
20%-denuded bone is completely ﬁlled in 1 year, which cannot be solely
the result of matrix synthesis by resident chondrocytes.We hypothesize
that MSCs play a trophic role on resident chondrocytes. The intra-
articular intermittent hydrostatic pressure (IHP) in the human knee
during distraction is thought to induce activation of this trophic effect.
The current study evaluates the effect of IHP on in vitro expression of
regenerative mediators in hMSCs.
Methods: The IHP culture setup consists of twovessels, a pressure vessel
and a control vessel. IHP between Patm and Patm þ 15 kPa, (as found in
vivo) is applied to the cells at a frequency of 0.33Hz. The vessels are
placed in a regular incubator (T¼ 37 C, [O2]¼ 20%, [CO2]¼ 5%, RH¼95%.
Bone marrow derived human MSCs (n¼5 donors) monolayer culture
was performed in the IHP setup for 6h, 24h and 48h. mRNA expression
levels for a set of cartilage-homeostasis related genes were determined,using hypoxanthine phosphoribosyltransferase (HPRT1) as a reference
gene. Targets were; ﬁbroblast growth factor 1, 2 and 18 (FGF1, 2, 18),
tissue inhibitor of metalloproteinase 1 and 2 (TIMP1,2), transforming
growth factor b 1 (TGFb1), insulin-like growth factor 1 (IGF1) and
hepatocyte growth factor (HGF). The comparative Ct method (DCt/
DDCt) was used to analyse the qPCR data.
Results: IHP affected gene expression of cartilage-homeostasis related
targets with a large inter donor variation (ﬁgure 1). Overall, mild
upregulation of FGF2 and TGFb1 was already seen after 6h under IHP.
FGF1 expression shows hardly an effect, and amild downregulationwas
seen for FGF18, TIMP1 IGF1 and HGF. Interestingly, TIMP2 shows a
signiﬁcant downregulation for all donors.
Conclusions: Under IHC a mild early upregulation of FGF2, TGFb1 and a
mild downregulation of FGF18, TIMP1, IGF1 and HGF was seen. TIMP2 is
the only target that shows a signiﬁcant downregulation for all donors.
This data suggests a ﬁrst step in an early regenerative response upon
IHC in hMSCs. Additional experiments are warranted to further eluci-
date the exact role of IHP on hMCS.
Figure 1. mRNA expression of of cartilage-homeostasis related genes
under inﬂuence of IHP.
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PROXIMAL EFFECTS OF UNLOADER BRACING FOR MEDIAL KNEE
OSTEOARTHRITIS
F. Halfdanardottir y, þ. Ingvarsson z, K. Briem y. yUniv. of Iceland,
Reykjavík, Iceland; z €Ossur, Reykjavík, Iceland
Purpose: Persons with medial knee osteoarthritis (OA) are thought to
adopt increased frontal plane trunk sway to reduce medial compart-
ment loading. This type of compensatory motion may affect bilateral
muscle function and loading of the lower extremity joints, and thereby
impact risk of developing multi-articular OA. Unloading valgus knee
